WIN378

DRUG3 trials

Sponsors

Windward Bio AG, Windward Bio

Conditions

AsthmaAsthma (Diagnosis)COPD (Chronic Obstructive Pulmonary Disease)

Phase 2

Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe Asthma

Active, not recruitingNCT07120503

Windward BioAsthma (Diagnosis)

Start: 2025-07-24End: 2027-10-01Target: 136Updated: 2026-04-07

A Phase 2 Randomized, Double-blind Placebo-Controlled Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety and Efficacy of WIN378 in Adult Participants with Moderate or Severe Asthma

RecruitingCTIS2025-521391-58-00

Windward Bio AGAsthma

Start: 2025-11-28Target: 141Updated: 2026-01-15

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

RecruitingNCT07646587

Windward BioCOPD (Chronic Obstructive Pulmonary Disease)

Start: 2026-06-02End: 2028-01-07Target: 105Updated: 2026-09-15